To expand our findings of CCL2 and CCL5 regulated by lncSNHG5-ZNF281 signaling in promoting tumor metastasis, we evaluated CCL2 and CCL5 levels in tumor tissues and serum CCL2 and CCL5 of healthy donors and BC patients with or without metastasis. This evidence concerns the gene CCL2 and breast cancer.